中国药物警戒 ›› 2021, Vol. 18 ›› Issue (11): 1062-1065.
DOI: 10.19803/j.1672-8629.2021.11.14

• 法规与管理研究 • 上一篇    下一篇

从国际协调文件探讨医疗器械临床评价的思路

鞠珊, 刘英慧, 王雅文, 滕颖影, 蒋研, 邓刚, 孙磊*   

  1. 国家药品监督管理局医疗器械技术审评中心临床与生物统计一部,北京 100022
  • 收稿日期:2021-03-15 发布日期:2021-11-18
  • 通讯作者: *孙磊,男,本科,医疗器械临床评价技术审评。E-mail:sunlei@cmde.org.cn #为共同通信作者。
  • 作者简介:鞠珊,女,硕士,医疗器械临床评价技术审评。为并列第一作者。
  • 基金资助:
    国家重点研发计划(2018YFC0117100)

Clinical Evaluation of Medical Devices Seen from International Coordination Documents

JU Shan, LIU Yinghui, WANG Yawen, TENG Yingying, JIANG Yan, DENG Gang, SUN Lei*   

  1. Clinical Evaluation and Biometrics Division I, Center of Medical Device Technical Evaluation of National Medical Product Administration, Beijing 100022, China
  • Received:2021-03-15 Published:2021-11-18

摘要: 临床评价是审评医疗器械风险受益是否满足上市标准的重要组成部分,通过临床评价所生成的临床证据可作为监管决策的支持性证据。国内外监管机构、医疗器械生产商、行业相关团体对医疗器械的临床评价均予以高度的重视和关注。医疗器械临床评价工作组(Medical Device Clinical Evaluation Working Group)是国际医疗器械监管机构论坛(International Medical Device Regulators Forum, IMDRF)管理委员会于2018年3月批准成立的,由国家药品监督管理局医疗器械技术审评中心牵头的工作组,工作组经过18个月的调研和讨论起草了3篇临床评价相关指南文件,于2019年9月通过IMDRF管理委员会批准并发布。本文通过概述3篇指南文件内容,讨论我国医疗器械临床评价的进展与3篇指南文件对我国临床评价工作的启示,提出我国临床评价工作所面临的挑战,为进一步研究适合我国医疗器械技术审评现况的临床评价方法提供参考。

关键词: 临床评价, 医疗器械, 临床数据, 临床试验, 临床证据, 技术审评

Abstract: Clinical evaluation is critical to the determination of whether the risk benefit of medical devices meets the criteria for marketing authorization. The clinical evidence generated from clinical evaluation can be used as supporting evidence for regulatory decision-making. The clinical evaluation of medical devices is a top priority for domestic and foreign regulatory authorities, medical device manufacturers and stakeholders. The Medical Device Clinical Evaluation Working Group was established by the International Medical Device Regulators Forum (IMDRF) Management Committee in March 2018. It is a working group led by the Center of Medical Device Evaluation of the National Medical Products Administration. This working group drafted clinical evaluation-related documents after 18 months of research and discussion, which were approved and released by the IMDRF Management Committee in September 2019. The contents and main ideas of the three documents are summarized in this article. The progress in the clinical evaluation of medical devices in China and the implications of the three documents for clinical evaluation in China are discussed, and the challenges facing clinical evaluation in China are mentioned. This article is intended to provide reference for future research on clinical evaluation methods that are practical in China.

Key words: clinical evaluation, medical devices, clinical data, clinical investigation, clinical evidence, technical review

中图分类号: